2023
ACLP Best Practice Guidance: Evaluation and Treatment of Depression in Solid Organ Transplant Recipients
Zimbrean P, Andrews S, Hussain F, Fireman M, Kuntz K, Niazi S, Simpson S, Soeprono T, Winder G, Jowsey-Gregoire S. ACLP Best Practice Guidance: Evaluation and Treatment of Depression in Solid Organ Transplant Recipients. Journal Of The Academy Of Consultation-Liaison Psychiatry 2023, 64: 357-370. PMID: 37003570, DOI: 10.1016/j.jaclp.2023.03.007.Peer-Reviewed Original ResearchConceptsOrgan transplant recipientsSolid organ transplant recipientsTransplant recipientsDepressive disorderFirst-line antidepressantsTreatment of depressionMental health carePosttransplant depressionSOT recipientsTransplant patientsTreating providerClinical evaluationPositive screeningTreatment interventionsPatientsRecipientsHealth careDepressionDisordersConsensus processFrequent problemSpecial Interest GroupTreatmentPractice guidanceBest practice guidance
2021
Management of Substance Use Disorders in a Patient With Left Ventricular Assist Device
Choi J, Alexis J, Gosev I, Zimbrean P, Nickels M. Management of Substance Use Disorders in a Patient With Left Ventricular Assist Device. Journal Of The Academy Of Consultation-Liaison Psychiatry 2021, 62: 568-576. PMID: 34391977, DOI: 10.1016/j.jaclp.2021.07.015.Peer-Reviewed Original ResearchConceptsSubstance use disordersUse disordersVentricular assist deviceHeart failureAssist deviceAdvanced heart failureChallenging patient populationHeart failure managementRole of LVADsLVAD candidatesConsultation-liaison psychiatryCardiac surgeryPatient populationPatient outcomesClinical casesPatientsFailure managementDisordersLVADAvailable literatureTreatmentLimited literatureSurgeryFailureManagement
2019
Chapter 19 Wilson Disease Psychiatric Aspects
Zimbrean P. Chapter 19 Wilson Disease Psychiatric Aspects. 2019, 215-225. DOI: 10.1016/b978-0-12-810532-0.00019-7.Peer-Reviewed Original ResearchQuality of lifeWilson's diseasePsychiatric presentationsGoals of careNewer psychotropic medicationsIrreversible cognitive declineCommon presentationNeurological findingsSymptomatic treatmentPsychotropic medicationsCurrent treatmentGeneral populationPsychiatric aspectsCognitive declineFunctional psychosesWD patientsCognitive deficitsMood instabilitySymptomsTreatmentPresentationSecondary effectsRemissionMedicationsPatientsChapter 14 Psychiatric Symptoms in WD
Zimbrean P. Chapter 14 Psychiatric Symptoms in WD. 2019, 159-170. DOI: 10.1016/b978-0-12-811077-5.00014-1.Peer-Reviewed Original ResearchWilson's diseasePsychiatric presentationsGoals of careNewer psychotropic medicationsSevere side effectsQuality of lifeIrreversible cognitive declineNeurological findingsPatients' qualitySymptomatic treatmentPsychotropic medicationsCurrent treatmentPsychiatric symptomsMood symptomsGeneral populationSide effectsFunctional psychosesCognitive declineWD patientsCognitive deficitsMood instabilitySymptomsTreatmentPresentationRemission